Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ironwood Pharmaceuticals Inc.
DescriptionSoluble guanylate cyclase (sGC) stimulator
Molecular Target Soluble guanylate cyclase (sGC)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat vascular and fibrotic diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today